33
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Molecular engineering solutions for therapeutic peptide delivery

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This review discusses self-assembled vehicles as nanoparticles to carry and protect therapeutic peptides through their journeys in the body.

          Abstract

          Proteins and their interactions in and out of cells must be well-orchestrated for the healthy functioning and regulation of the body. Even the slightest disharmony can cause diseases. Therapeutic peptides are short amino acid sequences (generally considered <50 amino acids) that can naturally mimic the binding interfaces between proteins and thus, influence protein–protein interactions. Because of their fidelity of binding, peptides are a promising next generation of personalized medicines to reinstate biological harmony. Peptides as a group are highly selective, relatively safe, and biocompatible. However, they are also vulnerable to many in vivo pharmacologic barriers limiting their clinical translation. Current advances in molecular, chemical, and nanoparticle engineering are helping to overcome these previously insurmountable obstacles and improve the future of peptides as active and highly selective therapeutics. In this review, we focus on self-assembled vehicles as nanoparticles to carry and protect therapeutic peptides through this journey, and deliver them to the desired tissue.

          Related collections

          Most cited references145

          • Record: found
          • Abstract: not found
          • Article: not found

          Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

            The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies and recombinant proteins, poses substantial challenges owing to their large size and susceptibility to degradation. In this Review we highlight recent advances in formulation and delivery strategies--such as the use of microsphere-based controlled-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, and genetic manipulation of biopharmaceutical drugs--and discuss their advantages and limitations. We also highlight current and emerging delivery routes that provide an alternative to injection, including transdermal, oral and pulmonary delivery routes. In addition, the potential of targeted and intracellular protein delivery is discussed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Polymer conjugates as anticancer nanomedicines.

              The transfer of polymer-protein conjugates into routine clinical use, and the clinical development of polymer-anticancer-drug conjugates, both as single agents and as components of combination therapy, is establishing polymer therapeutics as one of the first classes of anticancer nanomedicines. There is growing optimism that ever more sophisticated polymer-based vectors will be a significant addition to the armoury currently used for cancer therapy.
                Bookmark

                Author and article information

                Journal
                CSRVBR
                Chemical Society Reviews
                Chem. Soc. Rev.
                Royal Society of Chemistry (RSC)
                0306-0012
                1460-4744
                2017
                2017
                : 46
                : 21
                : 6553-6569
                Affiliations
                [1 ]Institute for Molecular Engineering
                [2 ]The University of Chicago
                [3 ]Chicago
                [4 ]USA
                [5 ]Department of Pediatrics
                [6 ]Section of Hematology/Oncology
                [7 ]University of Chicago
                Article
                10.1039/C7CS00536A
                28902203
                fcd7a464-bdf7-431a-9ad5-68dbc6dd5f75
                © 2017
                History

                Comments

                Comment on this article